SEC 13F Intelligence

Clark Estates Inc/Ny / ABBV

Clark Estates Inc/Ny’s Abbvie Inc Position

Does Clark Estates Inc/Ny own Abbvie Inc (ABBV)? Not currently — the last reported position was 50.0K shares worth $8M in Q2 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$8M
Q2 2022
Shares
50.0K
% of Portfolio
+1.33%
Quarters Held
13
position exited

Position History ABBV

Reported value by quarter
Q2 ’19: $3MQ2 ’19Q3 ’19: $4MQ4 ’19: $4MQ4 ’19Q1 ’20: $4MQ2 ’20: $7MQ2 ’20Q3 ’20: $8MQ4 ’20: $11MQ4 ’20Q1 ’21: $12MQ2 ’21: $12MQ2 ’21Q3 ’21: $12MQ4 ’21: $15MQ4 ’21Q1 ’22: $13MQ2 ’22: $8MQ2 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202250.0K$8M+1.33%
Q1 202280.4K$13M+2.06%
Q4 2021107.3K$15M+2.13%
Q3 2021107.3K$12M+1.65%
Q2 2021107.3K$12M+1.58%
Q1 2021107.3K$12M+1.48%
Q4 2020103.4K$11M+1.56%
Q3 202087.9K$8M+1.26%
Q2 202066.4K$7M+1.14%
Q1 202048.0K$4M+0.74%
Q4 201948.0K$4M+0.65%
Q3 201948.0K$4M+0.60%
Q2 201948.0K$3M+0.56%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Clark Estates Inc/Ny’s full portfolio or all institutional holders of ABBV.